Critical pathways to success in CNS drug development
I tiakina i:
| Kaituhi rangatōpū: | |
|---|---|
| Ētahi atu kaituhi: | |
| Hōputu: | Tāhiko īPukapuka |
| Reo: | Ingarihi |
| I whakaputaina: |
Chichester, UK ; Hoboken, NJ :
Wiley-Blackwell,
2010.
|
| Ngā marau: | |
| Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
| Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ngā tūemi rite
Drugs, society & human behavior /
mā: Ray, Oakley Stern
I whakaputaina: (1996)
mā: Ray, Oakley Stern
I whakaputaina: (1996)
Drug concentrations in neuropsychiatry
I whakaputaina: (1980)
I whakaputaina: (1980)
Drugs of abuse : pharmacology and molecular mechanisms /
mā: Howard, Sherrel G.
I whakaputaina: (2014)
mā: Howard, Sherrel G.
I whakaputaina: (2014)
Principles of CNS drug development from test tube to patient /
mā: Kelly, John, 1961-
I whakaputaina: (2009)
mā: Kelly, John, 1961-
I whakaputaina: (2009)
Drug interactions in psychiatry /
I whakaputaina: (2006)
I whakaputaina: (2006)
Neuropsychopharmacology : an official publication of the American College of Neuropsychopharmacology /
I whakaputaina: (2002)
I whakaputaina: (2002)
Blood-brain barrier in drug discovery : optimizing brain exposure of CNS drugs and minimizing brain side effects for peripheral drugs /
I whakaputaina: (2015)
I whakaputaina: (2015)
Drugs, society, and human behavior /
mā: Ksir, Charles
I whakaputaina: (2008)
mā: Ksir, Charles
I whakaputaina: (2008)
Neuropsychedelia the revival of hallucinogen research since the decade of the brain /
mā: Langlitz, Nicolas, 1975-
I whakaputaina: (2013)
mā: Langlitz, Nicolas, 1975-
I whakaputaina: (2013)
Practical management of the side effects of psychotropic drugs
I whakaputaina: (1999)
I whakaputaina: (1999)
Drugs, society, and human behavior /
mā: Hart, Carl L.
I whakaputaina: (2009)
mā: Hart, Carl L.
I whakaputaina: (2009)
Comité de Expertos de la OMS en Farmacodependencia 34o informe.
I whakaputaina: (2007)
I whakaputaina: (2007)
Pharmacogenetics of psychotropic drugs
I whakaputaina: (2002)
I whakaputaina: (2002)
WHO Expert Committee on Drug Dependence thirty-fourth report.
I whakaputaina: (2006)
I whakaputaina: (2006)
Uppers, downers, all arounders : physical and mental effects of psychoactive drugs /
mā: Inaba, Darryl
I whakaputaina: (2014)
mā: Inaba, Darryl
I whakaputaina: (2014)
Comite de Expertos de los OMS en Farmacodependencia 33o informe /
I whakaputaina: (2003)
I whakaputaina: (2003)
Neuroscience of psychoactive substance use and dependence
I whakaputaina: (2004)
I whakaputaina: (2004)
The Maudsley prescribing guidelines in psychiatry /
mā: Taylor, David, 1946-, me ētahi atu.
I whakaputaina: (2015)
mā: Taylor, David, 1946-, me ētahi atu.
I whakaputaina: (2015)
The use and misuse of psychiatric drugs an evidence-based critique /
mā: Paris, Joel, 1940-
I whakaputaina: (2010)
mā: Paris, Joel, 1940-
I whakaputaina: (2010)
Happy pills in America : from Miltown to Prozac /
mā: Herzberg, David L. (David Lowell)
I whakaputaina: (2009)
mā: Herzberg, David L. (David Lowell)
I whakaputaina: (2009)
Translational neuroscience : toward new therapies /
I whakaputaina: (2015)
I whakaputaina: (2015)
Clinical trials in psychopharmacology a better brain /
I whakaputaina: (2010)
I whakaputaina: (2010)
Amphetamines neurobiological mechanisms, pharmacology and effects /
I whakaputaina: (2012)
I whakaputaina: (2012)
Handbook of radiosurgery in CNS disease
I whakaputaina: (2013)
I whakaputaina: (2013)
Post-genomic approaches in drug and vaccine development /
I whakaputaina: (2015)
I whakaputaina: (2015)
Neuroinflammation and CNS disorders /
I whakaputaina: (2014)
I whakaputaina: (2014)
Pharmacological treatment of mental disorders in primary health care
I whakaputaina: (2009)
I whakaputaina: (2009)
Improving access and use of psychotropic medicines mental health policy and service guidance package.
I whakaputaina: (2004)
I whakaputaina: (2004)
The creation of psychopharmacology
mā: Healy, David, MRC Psych
I whakaputaina: (2002)
mā: Healy, David, MRC Psych
I whakaputaina: (2002)
Specification of drug substances and products : development and validation of analytical methods /
I whakaputaina: (2014)
I whakaputaina: (2014)
The biochemical basis of neuropharmacology /
mā: Cooper, Jack R., 1924-
I whakaputaina: (1986)
mā: Cooper, Jack R., 1924-
I whakaputaina: (1986)
Antitargets and drug safety /
I whakaputaina: (2015)
I whakaputaina: (2015)
Biological drug products : development and strategies /
I whakaputaina: (2013)
I whakaputaina: (2013)
Inflammatory cells and mediators in CNS diseases
I whakaputaina: (1999)
I whakaputaina: (1999)
Critical path analysis for development administration /
mā: Packard, Philip C.
I whakaputaina: (1972)
mā: Packard, Philip C.
I whakaputaina: (1972)
Multiple sclerosis and CNS inflammatory disorders /
I whakaputaina: (2014)
I whakaputaina: (2014)